These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 25257526)

  • 21. Studies of tricyclic piperazine/piperidine furnished molecules as novel integrin αvβ3/αIIbβ3 dual antagonists using 3D-QSAR and molecular docking.
    Yan Y; Li Y; Zhang S; Ai C
    J Mol Graph Model; 2011 Feb; 29(5):747-62. PubMed ID: 21273104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of novel, orally available benzimidazoles as melanin concentrating hormone receptor 1 (MCHR1) antagonists.
    Sasmal PK; Sasmal S; Rao PT; Venkatesham B; Roshaiah M; Abbineni C; Khanna I; Jadhav VP; Suresh J; Talwar R; Muzeeb S; Receveur JM; Frimurer TM; Rist Ø; Elster L; Högberg T
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5443-8. PubMed ID: 20724156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of the structural features of quinazoline derivatives as EGFR inhibitors using 3D-QSAR modeling, molecular docking, molecular dynamics simulations and free energy calculations.
    Wang F; Yang W; Liu H; Zhou B
    J Biomol Struct Dyn; 2022; 40(21):11125-11140. PubMed ID: 34338597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CoMFA, CoMSIA, Topomer CoMFA, HQSAR, molecular docking and molecular dynamics simulations study of triazine morpholino derivatives as mTOR inhibitors for the treatment of breast cancer.
    Chhatbar DM; Chaube UJ; Vyas VK; Bhatt HG
    Comput Biol Chem; 2019 Jun; 80():351-363. PubMed ID: 31085426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Melanin concentrating hormone receptor 1 (MCHR1) antagonists-Still a viable approach for obesity treatment?
    Högberg T; Frimurer TM; Sasmal PK
    Bioorg Med Chem Lett; 2012 Oct; 22(19):6039-47. PubMed ID: 22954736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of 3D-QSAR, Pharmacophore, and Molecular Docking in the Molecular Design of Diarylpyrimidine Derivatives as HIV-1 Nonnucleoside Reverse Transcriptase Inhibitors.
    Liu G; Wang W; Wan Y; Ju X; Gu S
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29751616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of three-dimensional shape and electrostatic similarity searching in the identification of a melanin-concentrating hormone receptor 1 antagonist.
    Muchmore SW; Souers AJ; Akritopoulou-Zanze I
    Chem Biol Drug Des; 2006 Feb; 67(2):174-6. PubMed ID: 16492165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and evaluation of 2-amino-8-alkoxy quinolines as MCHr1 antagonists. Part 2.
    Vasudevan A; Wodka D; Verzal MK; Souers AJ; Gao J; Brodjian S; Fry D; Dayton B; Marsh KC; Hernandez LE; Ogiela CA; Collins CA; Kym PR
    Bioorg Med Chem Lett; 2004 Oct; 14(19):4879-82. PubMed ID: 15341943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-Activity Relationships Based on 3D-QSAR CoMFA/CoMSIA and Design of Aryloxypropanol-Amine Agonists with Selectivity for the Human β3-Adrenergic Receptor and Anti-Obesity and Anti-Diabetic Profiles.
    Lorca M; Morales-Verdejo C; Vásquez-Velásquez D; Andrades-Lagos J; Campanini-Salinas J; Soto-Delgado J; Recabarren-Gajardo G; Mella J
    Molecules; 2018 May; 23(5):. PubMed ID: 29772697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amine-free melanin-concentrating hormone receptor 1 antagonists: Novel 1-(1H-benzimidazol-6-yl)pyridin-2(1H)-one derivatives and design to avoid CYP3A4 time-dependent inhibition.
    Igawa H; Takahashi M; Shirasaki M; Kakegawa K; Kina A; Ikoma M; Aida J; Yasuma T; Okuda S; Kawata Y; Noguchi T; Yamamoto S; Fujioka Y; Kundu M; Khamrai U; Nakayama M; Nagisa Y; Kasai S; Maekawa T
    Bioorg Med Chem; 2016 Jun; 24(11):2486-2503. PubMed ID: 27112449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rational design of methicillin resistance staphylococcus aureus inhibitors through 3D-QSAR, molecular docking and molecular dynamics simulations.
    Ballu S; Itteboina R; Sivan SK; Manga V
    Comput Biol Chem; 2018 Apr; 73():95-104. PubMed ID: 29475176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melanin-concentrating hormone receptor 1 antagonists. Synthesis and structure-activity relationships of novel 3-(aminomethyl)quinolines.
    Kamata M; Yamashita T; Imaeda T; Tanaka T; Masada S; Kamaura M; Kasai S; Hara R; Sasaki S; Takekawa S; Asami A; Kaisho T; Suzuki N; Ashina S; Ogino H; Nakano Y; Nagisa Y; Kato K; Kato K; Ishihara Y
    J Med Chem; 2012 Mar; 55(5):2353-66. PubMed ID: 22309223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of docking-based 3D QSAR models for the design of substituted quinoline derivatives as human dihydroorotate dehydrogenase (hDHODH) inhibitors.
    Vyas VK; Ghate M
    SAR QSAR Environ Res; 2013 Aug; 24(8):625-45. PubMed ID: 23714018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3D-QSAR Studies on Barbituric Acid Derivatives as Urease Inhibitors and the Effect of Charges on the Quality of a Model.
    Ul-Haq Z; Ashraf S; Al-Majid AM; Barakat A
    Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27144563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Docking-based 3D-QSAR (CoMFA, CoMFA-RG, CoMSIA) study on hydroquinoline and thiazinan-4-one derivatives as selective COX-2 inhibitors.
    Dowlati Beirami A; Hajimahdi Z; Zarghi A
    J Biomol Struct Dyn; 2019 Jul; 37(11):2999-3006. PubMed ID: 30035675
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Liu J; Feng K; Ren Y
    J Biomol Struct Dyn; 2019 Sep; 37(14):3803-3821. PubMed ID: 30261821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computational Analysis of CRTh2 receptor antagonist: A Ligand-based CoMFA and CoMSIA approach.
    Babu S; Sohn H; Madhavan T
    Comput Biol Chem; 2015 Jun; 56():109-21. PubMed ID: 25935115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring the structure determinants of pyrazinone derivatives as PDE5 3HC8 inhibitors: an in silico analysis.
    Li Y; Wu W; Ren H; Wang J; Zhang S; Li G; Yang L
    J Mol Graph Model; 2012 Sep; 38():112-22. PubMed ID: 23085160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3D-QSAR (CoMFA, CoMSIA), molecular docking and molecular dynamics simulations study of 6-aryl-5-cyano-pyrimidine derivatives to explore the structure requirements of LSD1 inhibitors.
    Ding L; Wang ZZ; Sun XD; Yang J; Ma CY; Li W; Liu HM
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3521-3528. PubMed ID: 28610981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3D-QSAR study of ring-substituted quinoline class of anti-tuberculosis agents.
    Nayyar A; Malde A; Jain R; Coutinho E
    Bioorg Med Chem; 2006 Feb; 14(3):847-56. PubMed ID: 16214351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.